HGH Fragment 176-191 vs Tesamorelin

Overview

HGH Fragment 176-191 and Tesamorelin are both performance & growth peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares HGH Fragment 176-191 and Tesamorelin across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Key differences

Primary use. HGH Fragment 176-191 is categorised under Performance & Growth, while Tesamorelin falls under Performance & Growth. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. HGH Fragment 176-191: not FDA-approved; treated as a research compound. Tesamorelin: FDA-approved.

Dosing. HGH Fragment 176-191 is typically dosed at 250-500 mcg (daily). Tesamorelin is typically dosed at 2 mg (daily).

Can you stack them?

Some protocols combine peptides, but stacking HGH Fragment 176-191 and Tesamorelin has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between HGH Fragment 176-191 and Tesamorelin?

HGH Fragment 176-191 and Tesamorelin are both performance & growth peptides, but they differ in mechanism, dosing, and regulatory status. HGH Fragment 176-191 is not FDA-approved; generally classified as a research compound, whereas Tesamorelin is FDA-approved for one or more indications.

What is HGH Fragment 176-191 used for?

Fat loss without GH effects.

What is Tesamorelin used for?

GHRH for visceral fat.

Can you take HGH Fragment 176-191 and Tesamorelin together?

Some users combine peptides within a single protocol, but stacking HGH Fragment 176-191 and Tesamorelin has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.

Is HGH Fragment 176-191 or Tesamorelin FDA-approved?

HGH Fragment 176-191 is not FDA-approved; generally classified as a research compound. Tesamorelin is FDA-approved for one or more indications.